High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
主要な著者: | Yue, W, Oppermann, U |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
類似資料
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
著者:: Yue, W, 等
出版事項: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
著者:: Yue, W, 等
出版事項: (2011) -
Structural genomics and high throughput structural biology /
著者:: Sundstrom, Michael, 等
出版事項: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
著者:: Oppermann, U, 等
出版事項: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
著者:: Oppermann, U, 等
出版事項: (2000)